Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREYour new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESJuly 29, 2021
Calendar11:00am - 12:00pm
GMT-04:00
After delays and uncertainty, the countdown to IDMP is getting closer. The EMA will be the first health agency to mandate compliance with ISO IDMP, with the FDA not far behind. Pharma organizations face a rapidly shortening timeframe to prepare for full transition of regulatory data and systems to comply with this complex mandate.
Publication of the EU Implementation Guidelines v2 in February 2021 started the 2-year implementation window. EU IG V2.1 is due out in June 2021. And, in Q1 2022, the EMA expects pharma companies to be able to submit product data in IDMP format, and by Q1 2023, this will be mandatory.
IDMP (Identification of Medicinal Products) refers to a set of standards designed to standardize the structure and terminology used to describe marketed medicinal products. IDMP's primary goal is to enhance patient safety by improving the speed, accuracy, consistency, and sharing of adverse events and safety signal reporting globally.
Capturing the hundreds of data entities required per product, 70% of which lie in unconnected silos of unstructured text, demands time, resources, and investment.
However, manual curation is not the only option for extraction of the necessary data attributes. Linguamatics NLP text mining solution can save your organization significant time and reduce mistakes on its IDMP-compliance journey.
In this webinar, we will discuss the application of Linguamatics NLP for the extraction of key data elements from unstructured text, using Summary of Product Characteristic documents as an example.
Who should attend?
Directors and managers in regulatory affairs, operations, compliance; plus, information and knowledge management professionals responsible for master data management strategies, regulatory information management, IDMP implementation.
Jane Reed
Director of Life Science Linguamatics, an IQVIA company
Yannis Haldoupis
Senior Application Scientist Linguamatics, an IQVIA company